Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines.
Wang L, Kainulainen MH, Jiang N, Di H, Bonenfant G, Mills L, Currier M, Shrivastava-Ranjan P, Calderon BM, Sheth M, Mann BR, Hossain J, Lin X, Lester S, Pusch EA, Jones J, Cui D, Chatterjee P, Jenks MH, Morantz EK, Larson GP, Hatta M, Harcourt JL, Tamin A, Li Y, Tao Y, Zhao K, Lacek K, Burroughs A, Wang W, Wilson M, Wong T, Park SH, Tong S, Barnes JR, Tenforde MW, Self WH, Shapiro NI, Exline MC, Files DC, Gibbs KW, Hager DN, Patel M, Halpin AL, McMullan LK, Lee JS, Xia H, Xie X, Shi PY, Davis CT, Spiropoulou CF, Thornburg NJ, Oberste MS, Dugan VG; SSEV Bioinformatics Working Group; Wentworth DE, Zhou B.
Wang L, et al. Among authors: barnes jr.
Nat Commun. 2022 Jul 27;13(1):4350. doi: 10.1038/s41467-022-31929-6.
Nat Commun. 2022.
PMID: 35896523
Free PMC article.